CClinicalTrials.gg
CompletedNCT02875665Updated Feb 7, 2018

Feasibility Study of the Use of the gekoTM Device for Faecal Incontinence in Older People Living at Home or in Care Homes

An interventional study of geko(TM) device in Fecal Incontinence, sponsored by Firstkind Ltd. Completed at 1 site in United Kingdom. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2018-02-07.

Sponsored by Firstkind Ltd · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
60 Years and older
Sex
All
01

Study summary

This research aims to investigate the feasibility for the treatment of OnPulse(TM) for the treatment of faecal incontinence (FI) (including mixed faecal and urinary incontinence) in older people living at home or in a Care Home. It will determine patient acceptability, tolerability and usability of the T-2 gekoTM device for FI by assessing:

  1. device user factors: acceptability of use, ease of device placement, ease of device interface control and understanding of device instructions;
  2. tolerability of device: skin tolerability.
02

Conditions studied

  • Fecal Incontinence

Browse trials for

03

In context

Fecal Incontinence

312 studies on the registry are indexed under Fecal Incontinence; 57 are open to participants now.

This study's enrollment of 13 is below the median of 50 across 216 interventional studies indexed under Fecal Incontinence.

Browse Fecal Incontinence studies →

Lead sponsor

Firstkind Ltd is the lead sponsor of 22 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Male or Female
  2. Aged 60 and over?
  3. Reporting faecal incontinence of any severity
  4. Living in own home or a Care Home
  5. Able to understand the Patient Information Sheet and willing to sign the written Informed Consent Form.
  6. Able and willing to follow the protocol requirements.

Exclusion criteria

Exclusion Criteria:

  1. Patients or Carers unable to speak, read or understand English
  2. Patients or Carers unable to give informed consent because of lack of capacity
  3. Patients with leg conditions (such as a venous ulcer) that would preclude placement of the gekoTM device.
  4. Have implantable electronic devices
  5. Has sore, infected or inflamed areas, broken skin or skin eruptions for example phlebitis, thrombophlebitis, venous leg ulcers, varicose veins etc. in the region where the device would be fitted.
  6. Any cancerous lesions in the lower limb
  7. Is pregnant
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Experimental
    geko device arm

    geko™ devices (acting on the posterior tibial nerve) to be used on alternate days over seven days, for an hour per day

    Device: geko(TM) device

Interventions

  • Devicegeko(TM) device

    The geko(TM) device will be used to electrically stimulate the posterior tibial nerve

06

What researchers measure

Primary outcomes

  1. Reviewing the views of older people with faecal incontinence and their formal and informal carers on using the CE marked gekoTM tibial nerve stimulator device in their place of usual residence with regards to ease of use of the device and tolerability.

    Using semi-structured interview style with a topic guide pre and post treatment with gekoTM device- researching the views of the patients using their own words to describe what they felt using geko device. Interviews will be digitally recorded and professionally transcribed through verbatim. Data will be anonymised and analysed using a pragmatic thematic analysis (1). NVivo will be used to support the analysis.

    Time frame: 1 week

Secondary outcomes

  1. Studying the feasibility of older people or their carers applying the device

    Interviews performed post treatment will measure this aspect of the study

    Time frame: 1 week

  2. Skin reactions to using the device on the leg of older people measured by clinical examination

    digital photos will be takes pre and post treatment with geko TM device. The digital photos will be viewed in random order from each participant by a second researcher blinded as to before or after status, and rated for signs of skin reaction using the categories: none, mild, moderate and severe.

    Time frame: 1 week

07

Study locations

1 site
  • Sussex Community NHS Foundation Trust
    Brighton, East Sussex BN2 3EW, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 7, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02875665
Lead sponsor
Firstkind Ltd
Responsible party
Sponsor
First posted
Aug 23, 2016
Start date
Apr 2016
Primary completion
Aug 2017
Completion
Sep 30, 2017
Last update
Feb 7, 2018

Study contacts

Christine Norton, Prof
principal investigator · King's College London

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion